First Light Asset Management, LLC: Company Profile

Background

Overview

First Light Asset Management, LLC is a Delaware-based investment management firm specializing in healthcare and life sciences sectors. Established in September 2013, the firm focuses on identifying high-quality, reasonably priced growth-equity opportunities among publicly traded micro- to small/mid-cap companies. The firm's principal owner and CEO is Mathew P. Arens, who has nearly 30 years of experience in the investment field, particularly in healthcare companies. Prior to founding First Light, Arens served as president and senior portfolio manager at Kopp Investment Advisors, managing the firm's healthcare-focused investment strategy.

Mission and Vision

First Light's mission is to deliver exceptional, compassionate care provided by extraordinary people so that all those who are served may age with comfort, dignity, and independence in the place they call home. The firm's vision is to be the best healthcare workplace in the Northern Rivers, striving to maintain a family-friendly, respectful, supportive, and safe environment that is open to all walks of life.

Primary Area of Focus

The firm primarily targets companies developing transformative devices, technologies, and innovations that aim to save money and improve patient care. This focus aligns with their strategy of investing in sectors with robust growth potential, particularly within the healthcare and industrials sectors.

Industry Significance

First Light Asset Management holds significant positions in companies such as AtriCure Inc, Axogen Inc, Evolent Health Inc, Centessa Pharmaceuticals PLC, and Paragon 28 Inc. These investments reflect the firm's strategic approach to investing in sectors with robust growth potential.

Key Strategic Focus

Core Objectives

First Light's core objective is to identify and invest in high-quality, reasonably priced growth-equity opportunities among publicly traded micro- to small/mid-cap healthcare and life sciences companies. The firm aims to target companies developing transformative devices, technologies, and innovations that may save money and improve patient care.

Specific Areas of Specialization

The firm's specialization includes:

Healthcare and Life Sciences Investments: Focusing on companies within the healthcare and life sciences sectors that are developing innovative solutions.

Micro- to Small/Mid-Cap Companies: Targeting publicly traded companies in the micro- to small/mid-cap range, which may offer higher growth potential.

Key Technologies Utilized

While specific technologies utilized by First Light are not publicly disclosed, the firm's investment strategy emphasizes identifying companies developing transformative devices, technologies, and innovations in the healthcare sector.

Primary Markets or Conditions Targeted

First Light primarily targets the healthcare and life sciences sectors, focusing on companies that are developing transformative devices, technologies, and innovations aimed at improving patient care and reducing costs.

Financials and Funding

Funding History

As of February 23, 2015, First Light managed approximately $198.5 million in regulatory Advisory Client assets under a discretionary basis. The firm's portfolio includes significant positions in companies such as AtriCure Inc, Axogen Inc, Evolent Health Inc, Centessa Pharmaceuticals PLC, and Paragon 28 Inc.

Total Funds Raised

Specific details regarding the total funds raised by First Light Asset Management are not publicly disclosed.

Notable Investors

While individual investors are not publicly disclosed, the firm's significant holdings in various healthcare and life sciences companies indicate a diverse investor base.

Intended Utilization of Capital

The capital managed by First Light is utilized to invest in high-quality, growth-oriented healthcare and life sciences companies, focusing on those developing transformative devices, technologies, and innovations aimed at improving patient care and reducing costs.

Pipeline Development

As an investment management firm, First Light Asset Management does not develop its own products or clinical trials. Instead, it invests in companies with promising pipelines in the healthcare and life sciences sectors. For instance, the firm's portfolio includes companies like AtriCure Inc, which specializes in medical devices for atrial fibrillation, and Centessa Pharmaceuticals PLC, a pharmaceutical company with a diverse pipeline of drug candidates.

Technological Platform and Innovation

Proprietary Technologies

First Light Asset Management does not develop proprietary technologies. Instead, it invests in companies that are developing transformative devices, technologies, and innovations in the healthcare sector.

Significant Scientific Methods

The firm's investment strategy focuses on identifying companies developing transformative devices, technologies, and innovations that may save money and improve patient care.

Leadership Team

Mathew P. Arens

Position: Managing Member, Chief Executive Officer, and Senior Portfolio Manager

Professional Background: With nearly 30 years of experience in the investment field, particularly in healthcare companies, Arens founded First Light Asset Management in 2013. Prior to this, he served as president and senior portfolio manager at Kopp Investment Advisors, managing the firm's healthcare-focused investment strategy.

Brian C. Beh

Position: Member and President

Professional Background: Specific details regarding Brian C. Beh's professional background are not publicly disclosed.

Brett T. Johnson

Position: Member, Senior Research Analyst, and Chief Compliance Officer

Professional Background: Specific details regarding Brett T. Johnson's professional background are not publicly disclosed.

Leadership Changes

As of the latest available information, there have been no significant changes or appointments within First Light Asset Management's leadership team.

Competitor Profile

Market Insights and Dynamics

The healthcare and life sciences investment sector is highly competitive, with numerous firms targeting micro- to small/mid-cap companies. The market is characterized by rapid technological advancements and a constant need for innovation.

Competitor Analysis

First Light Asset Management competes with other investment firms specializing in healthcare and life sciences sectors. Key competitors include:

Health Catalyst Inc: A data and analytics technology company providing services to healthcare organizations.

Arrowhead Pharmaceuticals Inc: A biopharmaceutical company specializing in RNA-targeted therapies.

Halozyme Therapeutics Inc: A biotechnology company developing and commercializing novel therapies.

Strategic Collaborations and Partnerships

First Light Asset Management has a strategic collaboration with Health Catalyst Inc, where the firm's founder, Mathew P. Arens, serves as the largest shareholder and has been appointed to Health Catalyst's board of directors.

Operational Insights

First Light Asset Management differentiates itself through its focused investment strategy in the healthcare and life sciences sectors, targeting companies with transformative technologies and innovations. The firm's leadership team, led by Mathew P. Arens, brings extensive experience in healthcare investments, providing a competitive edge in identifying and capitalizing on growth opportunities.

Strategic Opportunities and Future Directions

First Light Asset Management continues to focus on identifying and investing in high-quality, growth-oriented healthcare and life sciences companies. The firm's strategic roadmap includes expanding its portfolio by targeting companies developing transformative devices, technologies, and innovations aimed at improving patient care and reducing costs. The firm's strong leadership and focused investment strategy position it well to achieve these objectives.